Literature DB >> 22442383

Microbial exposure during early life has persistent effects on natural killer T cell function.

Torsten Olszak1, Dingding An, Sebastian Zeissig, Miguel Pinilla Vera, Julia Richter, Andre Franke, Jonathan N Glickman, Reiner Siebert, Rebecca M Baron, Dennis L Kasper, Richard S Blumberg.   

Abstract

Exposure to microbes during early childhood is associated with protection from immune-mediated diseases such as inflammatory bowel disease (IBD) and asthma. Here, we show that in germ-free (GF) mice, invariant natural killer T (iNKT) cells accumulate in the colonic lamina propria and lung, resulting in increased morbidity in models of IBD and allergic asthma as compared with that of specific pathogen-free mice. This was associated with increased intestinal and pulmonary expression of the chemokine ligand CXCL16, which was associated with increased mucosal iNKT cells. Colonization of neonatal-but not adult-GF mice with a conventional microbiota protected the animals from mucosal iNKT accumulation and related pathology. These results indicate that age-sensitive contact with commensal microbes is critical for establishing mucosal iNKT cell tolerance to later environmental exposures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442383      PMCID: PMC3437652          DOI: 10.1126/science.1219328

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Philippe Stock; Everett Meyer; Mitchell Kronenberg; Stephane Sidobre; Toshinori Nakayama; Masaru Taniguchi; Michael J Grusby; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2003-03-31       Impact factor: 53.440

2.  Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells.

Authors:  Frank Heller; Ivan J Fuss; Edward E Nieuwenhuis; Richard S Blumberg; Warren Strober
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

3.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

Review 4.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

Review 5.  Toward an understanding of NKT cell biology: progress and paradoxes.

Authors:  Mitchell Kronenberg
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  Hay fever, hygiene, and household size.

Authors:  D P Strachan
Journal:  BMJ       Date:  1989-11-18

7.  Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma.

Authors:  M Pufulete; R Al-Ghnaniem; A Khushal; P Appleby; N Harris; S Gout; P W Emery; T A B Sanders
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 8.  The immunology of mucosal models of inflammation.

Authors:  Warren Strober; Ivan J Fuss; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

9.  CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells.

Authors:  J H Roark; S H Park; J Jayawardena; U Kavita; M Shannon; A Bendelac
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

10.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

Authors:  Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more
  640 in total

Review 1.  Contributions of the intestinal microbiome in lung immunity.

Authors:  Jeremy P McAleer; Jay K Kolls
Journal:  Eur J Immunol       Date:  2017-08-31       Impact factor: 5.532

Review 2.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

3.  Early exposure to germs and the Hygiene Hypothesis.

Authors:  Dale T Umetsu
Journal:  Cell Res       Date:  2012-04-24       Impact factor: 25.617

4.  Mucosal immunology: the good the gut bugs do.

Authors:  Olive Leavy
Journal:  Nat Rev Immunol       Date:  2012-04-13       Impact factor: 53.106

Review 5.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 6.  Guts, germs, and meals: the origin of type 1 diabetes.

Authors:  H Beyan; L Wen; R D Leslie
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 7.  Environmental factors and eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2018-05-02       Impact factor: 10.793

Review 8.  Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces.

Authors:  Sebastian Zeissig; Richard S Blumberg
Journal:  Curr Opin Immunol       Date:  2013-11-05       Impact factor: 7.486

9.  Chemically induced mouse models of acute and chronic intestinal inflammation.

Authors:  Stefan Wirtz; Vanessa Popp; Markus Kindermann; Katharina Gerlach; Benno Weigmann; Stefan Fichtner-Feigl; Markus F Neurath
Journal:  Nat Protoc       Date:  2017-06-01       Impact factor: 13.491

Review 10.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.